Proteomics-based expression library screening - a platform technology for rapid discovery of pathogen-specific markers of infection.
The development of new management modalities is imperative for reducing the global burden of infectious diseases. To develop a platform technology for rapid definition of comprehensive pathogen immunoproteomes (the repertoire of microbial proteins that elicit and interact with host immune responses). Standard molecular biology techniques were coupled with cutting-edge proteomics to develop proteomics-based expression library screening (PELS). Proof of principle of PELS was demonstrated by defining a comprehensive immunoproteome of the human gastrointestinal pathogen, Escherichia coli O157:H7, in bovine reservoirs in just 3 weeks. PELS, an immunoproteomics-based platform technology, is a rapid and inexpensive alternative to protein/antigen arrays/chips. It is applicable to any parasitic, fungal, viral or bacterial pathogen (or commensal) that: has a sequenced genome; can be cultured in the laboratory; and elicits host humoral immune responses during the process of infection/disease.